COMMUNIQUÉS West-GlobeNewswire

Trillium Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it [...]
Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources
11/04/2019
Experienced biopharmaceutical HR executive expands leadership team and supports growth as company advances portfolio of product candidates CAMBRIDGE, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding [...]
Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and [...]
FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada -- CFN Media
11/04/2019
SEATTLE, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin for injection) to Treat Complicated Urinary Tract Infections (cUTIs)
11/04/2019
New data continue to support lefamulin and CONTEPO as potential first-in-class antibiotics in the United States that target the most common causative pathogens of CABP and cUTI, including multi-drug resistant (MDR) [...]
Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer
11/04/2019
Proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumors including glioblastoma multiforme OTTAWA, April 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") ( [...]
Tetra Bio-Pharma et Ovensa s’engagent à collaborer pour lutter contre le cancer du cerveau
11/04/2019
Une plateforme de nanomédicine exclusive pour la livraison ciblée de cannabinoïdes aux tumeurs cérébrales, y compris le glioblastome multiforme OTTAWA, 11 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra [...]
Correction: Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 - without MAR plate
11/04/2019
Press release Correction: MAR plate removed from this press release Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 Oncology Venture A/S hereby announces a supplement to the [...]
Philips and Vietnamese Hong Duc General Hospital sign multi-year strategic partnership agreement
11/04/2019
11 April 2019 Philips to provide turnkey hospital solution to newly-built Hong Duc General Hospital II, including the latest medical imaging and healthcare IT solutions as well as design, consulting and financing [...]
Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019
11/04/2019
Press release 11th April 2019 at 09.30 local time (EEST) Biohit Oyj and Precision Health Co., Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand. The effectiveness of Acetium® lozenge [...]
Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
11/04/2019
- Launched Unyvero System and Unyvero LRT Cartridge in the U.S. - Increased revenues to EUR 1.4 million in 2018 - Raised EUR 19.5 million additional funding - Revised focus and strategy Amsterdam, the Netherlands, and [...]
Intercept Reports Additional Positive Data from REGENERATE, the First Successful Phase 3 Study in NASH
11/04/2019
OCA significantly improved fibrosis in patients with liver fibrosis due to NASH and demonstrated consistent efficacy across multiple histologic and biochemical parameters REGENERATE data to be presented during the [...]
Solo Growth Announces Listing on Frankfurt Stock Exchange
11/04/2019
CALGARY, Alberta, April 11, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS TM with the vision to become a premier [...]
Autolus Announces Pricing of Public Offering
11/04/2019
LONDON, April 10, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of an [...]
JDRF Canada is extremely pleased with the House of Commons Standing Committee on Health report on a Diabetes Strategy for Canada
11/04/2019
OTTAWA, April 10, 2019 (GLOBE NEWSWIRE) -- JDRF is very pleased with the 11 recommendations made today by the House of Commons Standing Committee on Health in their report: A Diabetes Strategy for Canada , in alignment [...]
Galapagos creates new warrant plans
10/04/2019
Mechelen, Belgium; 10 April 2019, 22.01 CET; regulated information -- Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its b oard of directors created 2,070,000 warrants under new warrant plans for the [...]
Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019
10/04/2019
CINCINNATI, April 10, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report second quarter 2019 financial results [...]
Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019
10/04/2019
SAN DIEGO, April 10, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL) announced that it had filed its quarterly report on Form 10-Q today. The report was filed earlier than usual to facilitate the closing of [...]
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
10/04/2019
RALEIGH, N.C., April 10, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI” or the “Company”) today announced that it is commencing an underwritten public offering of shares of [...]

Pages